These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 22681585)

  • 1. Nanosponges - a completely new nano-horizon: pharmaceutical applications and recent advances.
    Ahmed RZ; Patil G; Zaheer Z
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1263-72. PubMed ID: 22681585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin based nanosponges for pharmaceutical use: a review.
    Tejashri G; Amrita B; Darshana J
    Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclodextrin-based nanosponges: a propitious platform for enhancing drug delivery.
    Chilajwar SV; Pednekar PP; Jadhav KR; Gupta GJ; Kadam VJ
    Expert Opin Drug Deliv; 2014 Jan; 11(1):111-20. PubMed ID: 24298891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug release from liquisolid systems: speed it up, slow it down.
    Nokhodchi A; Hentzschel CM; Leopold CS
    Expert Opin Drug Deliv; 2011 Feb; 8(2):191-205. PubMed ID: 21222556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications.
    Chiellini F; Piras AM; Errico C; Chiellini E
    Nanomedicine (Lond); 2008 Jun; 3(3):367-93. PubMed ID: 18510431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery strategies for poorly water-soluble drugs: the industrial perspective.
    van Hoogevest P; Liu X; Fahr A
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1481-500. PubMed ID: 21895540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silicon: a platform for the delivery of therapeutics.
    Prestidge CA; Barnes TJ; Lau CH; Barnett C; Loni A; Canham L
    Expert Opin Drug Deliv; 2007 Mar; 4(2):101-10. PubMed ID: 17335408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances and patents in solid dispersion technology.
    Iqbal B; Ali A; Ali J; Baboota S; Gupta S; Dang S; Shadab M; Sahni JK
    Recent Pat Drug Deliv Formul; 2011 Sep; 5(3):244-64. PubMed ID: 21834778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs.
    Kipp JE
    Int J Pharm; 2004 Oct; 284(1-2):109-22. PubMed ID: 15454302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanosponges: a novel class of drug delivery system--review.
    S S; S A; Krishnamoorthy K; Rajappan M
    J Pharm Pharm Sci; 2012; 15(1):103-11. PubMed ID: 22365092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse approaches for the enhancement of oral drug bioavailability.
    Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
    Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-ordered nanopore and nanotube platforms for drug delivery applications.
    Losic D; Simovic S
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1363-81. PubMed ID: 19860534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in intravenous delivery of poorly water-soluble compounds.
    Shi Y; Porter W; Merdan T; Li LC
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
    Muller RH; Keck CM
    J Biotechnol; 2004 Sep; 113(1-3):151-70. PubMed ID: 15380654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipospheres and pro-nano lipospheres for delivery of poorly water soluble compounds.
    Elgart A; Cherniakov I; Aldouby Y; Domb AJ; Hoffman A
    Chem Phys Lipids; 2012 May; 165(4):438-53. PubMed ID: 22342324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.